Dr. Post is Head of Regulatory Affairs Development, US Vaccines at Sanofi.  She is an experienced biopharmaceutical professional with a proven track record of successful development and implementation of regulatory strategies, progressing products from pre-clinical through global approval and post-marketing changes. She is the Regulatory head that led the team responsible for the filing and FDA approval of Flublok^®, the world’s first marketed recombinant influenza vaccine. Today she is responsible for the development and execution of US regulatory strategies for Sanofi’s vaccine pipeline and lifecycle assets in clinical development.  Dr. Post holds a B.A. in Biology from Middlebury College and a Ph.D. in Biochemistry and Cell Biology from Carnegie Mellon University.

Talks

• Accelerating Process Changes Through Comparability Protocols – Two Case Studies